For example, Zeng et al. found that the expression of miR-129-5p was significantly decreased in adriamycin (ADR)-resistant breast cancer cell lines and up-regulation of miR-129-5p suppressed adriamycin resistance in breast cancer by directly targeting SOX2 [7]. This evidence concerns the gene SOX2 and breast cancer.